http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-120189-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-50 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-56 |
filingDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d19e48c2eb078f4a0c3088d3e454c7d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2acd660c58f074e5e0a4ca73bf940d34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39d121f5b9b628c72f20ed8209de5613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac00da42ebe037d66c728e09c023d96 |
publicationDate | 2022-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-120189-A1 |
titleOfInvention | COMBINATIONS OF ACTIVE COMPOUNDS |
abstract | Claim 1: Combination of active compounds comprising (A) as compound (A) N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylimidoformamide, (B) as compound (B) another active compound selected from the following groups: respiratory chain inhibitors in complex I or II selected from the group consisting of (2,001) benzovindiflupyr, (2,002) bixaphene, (2,003) boscalide, (2,004) carboxin, (2.005) Fluopyram, (2.006) Flutolanil, (2.007) Fluxapiroxad, (2.008) Furametpyr, (2.009) Isofetamide, (2.010) Isopyrazam (1R,4S,9S anti-epimeric enantiomer), (2.011) Isopyrazam (1S,4R anti-epimeric enantiomer, 9R), (2.012) isopyrazam (1RS,4SR,9SR anti-epimeric racemate), (2.013) isopyrazam (mixture of 1RS,4SR,9RS syn-epimeric racemate and 1RS,4SR,9SR anti-epimeric racemate), (2.014) isopyrazam (syn- -epimeric 1R,4S,9R), (2.015) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (2.016) isopyrazam (syn-epimeric racemate 1RS,4SR,9RS), (2.017) penflufen, ( 2,018) Penthiopyrad, (2,019) Pidiflumetofen, (2,020) Pyraziflumide, (2,021) Sedaxane, (2,022) 1,3-Dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4 -yl)-1H-pyrazole-4-carboxamide, (2,023) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl] -1H-pyrazole-4-carboxamide, (2024) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H- pyrazole-4-carboxamide, (2.025) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026) 2-fluoro- 6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.027) 3-(difluoromethyl)-1-methyl-N-(1 ,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.028) inpyrfluxam, (2.029) 3-(difluoromethyl)-1-methyl-N- [(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) fluindapyr, (2.031) 3-(difluoromethyl)- N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) 3 -(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydr o-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.033) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl )pyridin-2-yl]oxy}-phenyl)ethyl]quinazolin-4-amine, (2.034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1 -methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole- 4-carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.037) N-(5 -chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.038) isoflucipram, (2.039) N-[(1R,4S) -9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2,040) N -[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4 -carboxamide, (2.041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.04 2) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.043) N-[3 -chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro -2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoromethyl)-5- fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2 -fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1 -methyl-1H-pyrazole-4-carboxamide, (2.048) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide, (2.049 ) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2,050) N-cyclopropyl-3-(difluoromethyl)-5- fluoro-N-(5-fluoro-2-isopropylbenzi l)-1-methyl-1H-pyrazole-4-carboxamide, (2,051) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide, (2.052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, ( 2.053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.054) N-cyclopropyl-N-( 2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)- 3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2,056) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl -1H-pyrazole-4-carboxamide, (2,057) pyrapropion, and complex III respiratory chain inhibitors selected from the group consisting of (3,001) ametoctradine, (3,002) amisulbrom, (3,003) azoxystrobin, (3,004) coumetoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamide, (3.007) dimoxystrobin, (3.008) enox astrobine, (3,009) famoxadone, (3,010) fenamidone, (3,011) fluphenoxystrobin, (3,012) fluoxastrobin, (3,013) kresoxim-methyl, (3,014) methomistrobin, (3,015) orysastrobin, (3,016) picoxystrobin, (3,017) pyraclostrobin, ( 3,018) Pyramethostrobin, (3,019) Pyroxystrobin, (3,020) Trifloxystrobin, (3,021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2 -phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H -pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl} -2-methoxy-N-methylacetamide, (3.024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) fenpicoxamide, (3.026) mandestrobin, (3.027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2 -fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029) {5-[3-(2,4-dimethylphenyl)-1H- pyrazol-1-yl]-2-methylbenzyl}carbamate methyl, (3,030) methyltetraprole, (3,031) florylpicoxamide, and (C) as compound (C) at least one other active compound selected from the following groups: (1) inhibitors of the respiratory chain in complex I or II, and ( 2) respiratory chain inhibitors in complex III, wherein the at least one other active compound (C) is different from compound (B). Claim 4: Combination of active compounds according to claim 1, wherein compound (B) is selected from: (2002) bixaphene, (2028) inpirfluxam, (2038) isoflucipram. Claim 5: Combination of active compounds according to any of claims 1 to 4, wherein compound (C) is selected from: (2,001) benzovindiflupyr, (2,002) bixaphene, (2,003) boscalide, (2,004) carboxin, ( 2,005) Fluopyram, (2,006) Flutolanil, (2,007) Fluxapiroxad, (2,008) Furametpyr, (2,009) Isofetamide, (2,010) Isopyrazam (1R,4S,9S anti-epimeric enantiomer), (2,011) Isopyrazam (1S,4R,9R anti-epimeric enantiomer ), (2.012) isopyrazam (1RS,4SR,9SR anti-epimeric racemate), (2.013) isopyrazam (mixture of 1RS,4SR,9RS syn-epimeric racemate and 1RS,4SR,9SR anti-epimeric racemate), (2.014) isopyrazam (syn- epimeric 1R,4S,9R), (2.015) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (2.016) isopyrazam (syn-epimeric racemate 1RS,4SR,9RS), (2.017) penflufen, (2.018) penthiopyrad, (2,019) Pidiflumetofen, (2,020) Pyraziflumide, (2,021) Sedaxane, (2,022) 1,3-Dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)- 1H-pyrazole-4-carboxamide, (2,023) 1,3-dimethyl l-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.024) 1,3-dimethyl-N-[ (3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.025) 1-methyl-3-(trifluoromethyl)-N- [2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3- dihydro-1H-inden-4-yl)benzamide, (2,027) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) -1H-pyrazole-4-carboxamide, (2028) inpyrfluxam, (2029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H- inden-4-yl]-1H-pyrazole-4-carboxamide, (2,030) fluindapyr, (2,031) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2, 3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2,032) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3 -trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.033) 5,8-difluoro-N-[2-(2-fluoro-4 -{[4-(trifluoromethyl)pyridin-2-yl]oxy}-phenyl)ethyl]quinazolin-4-amine, (2.034)N-(2-cyclopentyl-5-fluorobenz yl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl- 3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1 -methyl-1H-pyrazole-4-carboxamide, (2.037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- carboxamide, (2,038) isoflucipram, (2,039) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl )-1-methyl-1H-pyrazole-4-carboxamide, (2,040) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalene-5- yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2,041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl )-1-methyl-1H-pyrazole-4-carboxamide, (2,042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide, (2.043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluorom ethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro -1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H -pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047 ) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.048) N-cyclopropyl-3-(difluoromethyl )-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide, (2,049) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl) -1-methyl-1H-pyrazole-4-carboxamide, (2050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole- 4-carboxamide, (2.051) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.052) N-cyclopropyl-3-(difluoromethyl)-N-(2-e tyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2,053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5- fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2,054) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole -4-carboxamide, (2.055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.056) N -Cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.057) Pyropropoin, (3.001) Ametoctradine, (3.002) Amisulbrom, (3.003 ) Azoxystrobin, (3.004) Coumethoxystrobin, (3.005) Coumoxystrobin, (3.006) Cyazofamide, (3.007) Dimoxystrobin, (3.008) Enoxastrobin, (3.009) Famoxadone, (3.010) Fenamidone, (3.011) Fluphenoxystrobin, (3.012) Fluoxastrobin, (3.013) ) kresoxim-methyl, (3,014) methomistrobin, (3,015) orysastrobin, (3,016) picoxystrobin, (3,017) pyraclostrobin, (3,018) pyramethostrobin, (3,019) pyroxystrobin, (3,020) trifloxist robin, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy )methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2- (methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) fenpicoxamide, (3.026) mandestrobin, (3.027) N-(3-ethyl- 3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl] oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029) {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate methyl, (3.030) methyltetraprol, (3.031) florylpicoxamide. Claim 8: Combination of active compounds according to any of claims 1 to 4, wherein compound (C) is selected from: (2,005) fluopyram and (3,020) trifloxystrobin. Claim 11: Composition for controlling harmful microorganisms in crop protection and material protection, characterized by a content of a combination of active compounds according to at least one of claims 1 to 10, in addition to at least one carrier and / or surfactant Claim 12: Method for controlling harmful microorganisms in crop protection and material protection, characterized in that a combination of active compounds according to at least one of claims 1 to 10 or a composition according to claim 11 applies to harmful microorganisms and/or their habitat. |
priorityDate | 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.